Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR Fluorescence Imaging for SLNB in Breast Cancer
NCT03579979Completed
- Sponsor
- Chinese Academy of Sciences
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Chinese Academy of Sciences. Primary endpoint: Sentinel lymph node detection number at 1 year. Started Aug 2017; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03579979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579979.